LOW IL-1-BETA PRODUCTION IN LEUKEMIC-CELLS FROM PROGRESSIVE B-CELL CHRONIC LEUKEMIA (B-CLL)

被引：15
|
作者：
AGUILARSANTELISES, M
AMADOR, JF
MELLSTEDT, H
JONDAL, M
机构：
[1] KAROLINSKA INST,DEPT IMMUNOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA HOSP,RADIUM HEMMET,DEPT ONCOL,S-10401 STOCKHOLM,SWEDEN
[3] NATL INST ONCOL,HAVANA,CUBA
来源：
LEUKEMIA RESEARCH | 1989年 / 13卷 / 10期
关键词：
D O I：
10.1016/0145-2126(89)90048-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：937 / 942
页数：6
相关论文
共 50 条
  • [31] Prognostic relevance of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL)
    D'Arena, G.
    Napolitano, M.
    Marcacci, G.
    Russo, F.
    Vigliotti, M. L.
    Mauro, F.
    Corazzelli, G.
    Frigeri, F.
    Della Cioppa, P.
    Svanera, G.
    Capobianco, G.
    Nasuti, A.
    Villani, O.
    Pinto, A.
    CYTOMETRY PART A, 2006, 69A (05) : 449 - 449
  • [32] GENETIC PREDISPOSITION OF AUTOIMMUNE-DISEASE AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    SHIRAI, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 173 (01): : 133 - 140
  • [33] Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    Blonski, JZ
    Kasznicki, M
    Gora-Tybor, J
    Konopka, L
    Dmoszynska, A
    Skotnicki, AB
    Stella-Holowiecka, B
    Kuliczkowski, K
    Dwilewicz-Trojaczek, J
    BLOOD, 2000, 96 (11) : 293B - 293B
  • [34] Rituximab (Mabtera) in combination with dexamethasone as a treatment of resistant B-cell chronic lymphocytes leukemia (B-CLL)
    Katandjyan, N.
    Iosava, G.
    ALLERGY, 2008, 63 : 632 - 632
  • [35] Consolidation with rituximab improves outcome in high risk B-cell chronic lymphocytic leukemia (B-CLL)
    Del, Poeta G.
    Del, Principe M., I
    Maurillo, L.
    Buccisano, F.
    Niscola, F.
    Catalano, G.
    Venditti, A.
    Gattei, V
    Perrotti, A. P.
    de Fabritiis, F.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 23 - 23
  • [36] ACID-HYDROLASES IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) - A COMPARISON WITH NORMAL PERIPHERAL B LYMPHOCYTES AND NORMAL B-CELL SUBSET WITH THE PHENOTYPE OF B-LEUKEMIC CELLS
    PALESTRO, G
    NOVERO, D
    GODIO, L
    MICCA, FB
    RESEGOTTI, L
    STRAMIGNON, A
    LEUKEMIA RESEARCH, 1987, 11 (05) : 429 - 436
  • [37] Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells
    Secchiero, P
    Tiribelli, M
    Barbarotto, E
    Celeghin, C
    Michelutti, A
    Masolin, P
    Fanin, R
    Zauli, G
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (02) : 246 - 252
  • [38] Cytokine gene expression in a case of B-cell chronic lymphocytic leukemia (B-CLL) with an unusual expansion of T cells at presentation
    Mouzaki, A
    Kindler, V
    Bowers, N
    Doucet, A
    Melachrinou, M
    Kyrtsonis, MC
    KallinikouManiatis, A
    MOLECULAR BIOLOGY OF HEMATOPOIESIS 5, 1996, : 237 - 246
  • [39] Gene expression profiling of peripheral blood T cells in patients with indolent B-cell chronic lymphocytic leukemia (B-CLL)
    Kiaii, K.
    Osterborg, A.
    Mashayekhi, K.
    Moshfegh, A.
    Choudhury, A.
    Mellstedt, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 33 - 33
  • [40] The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
    Battle, TE
    Arbiser, J
    Frank, DA
    BLOOD, 2005, 106 (02) : 690 - 697
12345